(Q46570257)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Satoru Sharyo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Naoko Yokota-Ikeda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Miyuki Mori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Kazuyoshi Kumagai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Kazuyuki Uchida

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Katsuaki Ito

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Melissa J Burne-Taney

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Hamid Rabb

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

28 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

577-584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18509318%20AND%20SRC:MED&resulttype=core&format=json

Update on mechanisms of ischemic acute kidney injury

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Current perspectives on statins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Direct vascular effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Ischemic acute tubular necrosis models and drug discovery: a focus on cellular inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Postischemic acute renal failure is reduced by short-term statin treatment in a rat model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Atorvastatin improves the course of ischemic acute renal failure in aging rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Maladaptive role of IL-6 in ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Inhibition of Ras/ERK1/2 signaling protects against postischemic renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Effect of rapamycin on renal ischemia-reperfusion injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

No aggravation of renal injury in apolipoprotein E knockout mice (ApoE(-/-)) after subtotal nephrectomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Protective effect of L-arginine on hypercholesterolemia-enhanced renal ischemic injury.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

HMG-CoA reductase inhibitors and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Increased proximal tubular cholesterol content: implications for cell injury and "acquired cytoresistance"

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Renal cholesterol accumulation: a durable response after acute and subacute renal insults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Renal cortical cholesterol accumulation is an integral component of the systemic stress response

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Protective effect of an anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

Single-Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal Impairment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021

The pharmacokinetics of pravastatin in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.210

7 January 2021